Introduction {#sec1}
============

Known as important precursors for valuable chemicals, fatty acids have attracted tremendous attention for biological production of a variety of fatty acid derivatives, including biodiesel, fatty aldehydes, fatty alcohols, and alkanes/alkenes, some of which are promising substitutes for fossil fuels.^[@ref1]−[@ref3]^ A great deal of efforts have been made in the microbial production of fatty derivatives from fatty acids in recent years,^[@ref4],[@ref5]^ and particularly, *Saccharomyces cerevisiae* is regarded to be a potential natural cell factory based on its rapid growth rate, genetic traceability, robust genetic tools, high product yield, and good tolerance to harsh fermentation conditions.^[@ref6],[@ref7]^

In *S. cerevisiae*, biosynthesis of fatty acids is initiated by condensing acetyl-CoA and malonyl-CoA, and the final step is catalyzed by the transferase activity, which substitutes CoA for acyl carrier protein (ACP), releasing fatty acyl-CoAs.^[@ref8]^ The generated fatty acyl-CoAs are then fed into lipid storage, which mainly existed in the form of triacylglycerols (TAGs) or phospholipids. In addition, the free fatty acids (FFAs) in *S. cerevisiae* could be rapidly converted to fatty acyl-CoAs by fatty acyl-CoA synthetases, encoded by *FAA* genes.^[@ref9]^ The biosynthesis of fatty acid is in turn to be feedback inhibited by the fatty acyl-CoAs with an extremely low intracellular titer.^[@ref10],[@ref11]^ As such, the production level of both FFAs and fatty acyl-CoAs in *S. cerevisiae* is quite low.

Although fatty acids are important building blocks for fatty acid derivatives, their storage forms of TAGs or phospholipids are unable to be directly converted to the target components. A variety of converting enzymes, including wax ester synthase (WS)/acyltransferase (AT) for the synthesis of biodiesel,^[@ref12],[@ref13]^ fatty acyl-CoA reductase (FAR) for the synthesis of fatty alcohols/aldehydes,^[@ref14],[@ref15]^ aldehyde decarbonylase (AD)/carboxylic acid reductase (CAR) for the synthesis of fatty aldehyde,^[@ref16]−[@ref18]^ and others such as lipoxygenase (LOX) and hydroperoxide lyase (HPL),^[@ref19]^ all use FFAs or fatty acyl-CoAs as precursors. Thus, the activation of fatty acids through engineering the yeast cells is necessary for the efficient biosynthesis of the desired compounds.

In our previous study, the acyl-CoA-dependent TAG biosynthesis pathway was engineered by deleting the rate-limiting enzyme acyl-CoA:diacylglycerol acyltransferase (DAGAT) encoded by *dga*1, to accumulate fatty acyl-CoAs for the production of fatty acid derivatives. The subsequent overexpression of an alcohol-forming FAR successfully converted the accumulated fatty acyl-CoAs to fatty alcohols, resulting in the production of fatty alcohols in *S. cerevisiae* at a concentration of 45 mg/L.^[@ref15]^ This strategy ideally solved the bottleneck using the storage forms of fatty acids for the production of target derivatives. Because fatty acyl-CoA regulated the biosynthesis of fatty acids, the blockage of TAG synthesis pathway limited the metabolic flux toward the accumulation of fatty acyl-CoA. As such, further increase in fatty acid derivatives in the above-engineered strain is difficult to achieve.

To overproduce target derivatives, the regulatory inhibition by acyl-CoA should be relieved and the flux from fatty acyl-CoAs to FFAs is regarded to be a common strategy. Therefore, another strategy is then focused on the utilization of FFAs as precursors. We previously reported that deletion of *FAA*1 and *FAA*4 encoding two acyl-CoA synthetases together with the expression of acyl-CoA thioesterase (*acot*) successfully accumulated FFAs to a much higher level.^[@ref20]^ Among the converting enzymes, the CAR was discovered to be a versatile enzyme that can directly use FFAs to synthesize fatty acid derivatives, such as fatty aldehydes.^[@ref18]^ Therefore, *S. cerevisiae* was designed for metabolic engineering from this perspective in this study. On the basis of the *FAA*1/*FAA*4 deletion strain, the FFAs were expectedly accumulated and the CAR was then introduced into the mutant strain, to convert the accumulated FFAs to fatty acid derivatives. The final product produced in the engineered strain was compared with the previously engineered strains with modified TAG synthesis pathway, to investigate the productive capacity of fatty acid derivatives. The study herein aims to look for an alternative strategy realizing the efficient biosynthesis of fatty acid derivatives from the fatty acids in *S. cerevisiae*.

Results and Discussion {#sec2}
======================

Pathway Engineering for the Production of Enhanced Fatty Acid Derivatives {#sec2-1}
-------------------------------------------------------------------------

To realize the successful de novo production of fatty acid derivatives, a fatty acid-dependent pathway was metabolically engineered to supply efficient precursors. Differing from our previous strategy, which increased the production levels of fatty acyl-CoAs, the strategy herein aims to enhance the supply of FFAs. The *FAA*1 and *FAA*4 genes encoding the acyl-CoA synthetases were deleted according to the previous study, and the CAR was coexpressed with 4′-phosphopantetheinyl transferase (SFP) to convert the FFAs to their derivatives. To further increase the yield of fatty acid derivatives, the acyl-CoA:DAGAT was also deleted and the acyl-CoA thioesterase fragment was integrated into the genome of the engineered yeast, to block the formation of TAGs, resulting in the release of more FFAs ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Workflow of engineered pathway in *S. cerevisiae* for efficient biosynthesis of fatty acid derivatives based on the enhanced supply of FFAs as precursors. *FAA*1/*FAA*4: genes encoding the two acyl-CoA synthetases; *DGAI*: gene encoding the diglyceride acyltransferase; *acot*: gene encoding the acyl-CoA thioesterase from *M. musculus*; *car*: gene encoding the CAR from *M. marinum*; and *sfp*: gene encoding the SFP from *B. subtilis*. The designed pathway was indicated by red color.](ao-2017-00065v_0001){#fig1}

Efficient Release of FFAs Based on the Deletion of *FAA*1, *FAA*4, and *DGAI* and Introduction of *acot* {#sec2-2}
--------------------------------------------------------------------------------------------------------

According to the above strategy, the release of FFAs was investigated. The deletion of *FAA*1 and *FAA*4 encoding the acyl-CoA synthetases effectively increased the production level of FFAs. The FFAs mainly detected in Δ*FAA*1/Δ*FAA*4 strain were myristic acid (C14:0 fatty acid), cetyl acid (C16:0 fatty acid), palmitoleyl acid (C16:1 fatty acid), stearic acid (C18:0 fatty acid), and oleic acid (C18:1 fatty acid), and small amounts of octanoic acid (C8:0 fatty acid), capric acid (C10:0 fatty acid), and lauric acid (C12:0 fatty acid) was also observed. The codeletion of *DGAI* and the integration of *acot* further enhanced the production level of FFAs including C14:0, C16:0, C16:1, C18:0, and C18:1, with maximum yields of 18.3, 83.3, 92.1, 36.8, and 38.4 mg/L, which were increased by 43, 18, 15, 19, and 24%, respectively, compared with those of Δ*FAA*1/Δ*FAA*4 strain. However, the yield of medium-chain FFAs was not further increased ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). In the wild-type strain, even though small amounts of C16:0 and C18:0 were detected, other FFAs were not detectable. The C16:0 and C18:0 FFAs in the wild-type strain reached only about 24.2 and 10.6 mg/L, respectively, and the increase in C16:0 and C18:0 FFAs in the Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot* strain compared with the wild-type strain reached 244 and 247%, respectively.

![Fatty acid contents among the wild-type, Δ*FAA*1/Δ*FAA*4, and Δ*FAA*1/Δ*FAA*4/*DGAI*-*acot* strains. The standard deviation was calculated from the three independent experimental results.](ao-2017-00065v_0002){#fig2}

Efficient Synthesis of Fatty Acid Derivatives Based on Enhanced Supply of FFAs in Δ*FAA*1/Δ*FAA*4-*car*-*sfp*-Engineered Strain {#sec2-3}
-------------------------------------------------------------------------------------------------------------------------------

On the basis of the enhanced supply of FFAs, the coexpression of CAR and SFP successfully converted the individual FFAs into the corresponding fatty alcohols while no fatty aldehydes were detected. In the Δ*FAA*1/Δ*FAA*4-*car*-*sfp*-engineered strain, total fatty alcohols reached a concentration of 24.3 mg/L and the fatty alcohols mainly detected included 1-tetradecanol (C14:0 fatty alcohol), 1-hexadecanol (C16:0 fatty alcohol), *cis*-9-hexadecenol (C16:1 fatty alcohol), 1-octadecanol (C18:0 fatty alcohol), and *cis*-9-octadecenol (C18:1 fatty alcohol) ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), among which the *cis*-9-hexadecenol (C16:1) was found to be the most abundant, accounting for approximately 40.7% of the total fatty alcohols produced, followed by 1-hexadecanol (C16:0), 1-tetradecanol (C14:0), 1-octadecanol (C18:0), and *cis*-9-hexadecenol (C18:1), the concentrations of which accounted for 16.5, 11.4, 11.3, and 12.8%, respectively. Although detectable, 1-octanol (C8:0 fatty alcohol), 1-decanol (C10:0 fatty alcohol), and 1-dodecanol (C12:0 fatty alcohol) represented only less than 1.3, 3.1, and 2.7% of the total fatty alcohols, respectively ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), which was consistent with the profile of the accumulated FFAs in the Δ*FAA*1/Δ*FAA*4 double-deletion strain. Although the CAR and SFP were also coexpressed in the wild-type strain, only extremely small amounts of fatty alcohols were detected, including C16:0 fatty alcohol of 0.76 mg/L and C18:0 fatty alcohol of 0.33 mg/L, indicating the limited amount of FFAs produced in the wild-type strain.

![Production levels of fatty alcohol between the engineered strains Δ*FAA*1/Δ*FAA*4-*car*-*sfp* and Δ*FAA*1/Δ*FAA*4/*DGAI*-*acot*-*car*-*sfp*. The standard deviation was calculated from the three independent experimental results.](ao-2017-00065v_0003){#fig3}

###### Primers Used in This Study[a](#t1fn1){ref-type="table-fn"}

  gene          primer                                                                    description
  ------------- ------------------------------------------------------------------------- ------------------------------------------------------
  Δ*FAA*1-*F*   5′CAATAAAAACTAGAACAAACACAAAAGACAAAAAAAGACAACAATCAGCTGAAGCTTCGTACGC3′      forward primer for *FAA*1 gene deletion
  Δ*FAA*1-*R*   5′TGCTTTAGTATGATGAGGCTTTCCTATCATGGAAATGTTGATCCAGCATAGGCCACTAGTGGATCTG3′   reverse primer for *FAA*1 gene deletion
  Δ*FAA*4-*F*   5′TCTGTTCTTCACTATTTCTTGAAAAACTAAGAAGTACGCATCAAACAGCTGAAGCTTCGTACGC3′      forward primer for *FAA*4 gene deletion
  Δ*FAA*4-*R*   5′GTGTTTATGAAGGGCAGGGGGGAAAGTAAAAAACTATGTCTTCCTGCATAGGCCACTAGTGGATCTG3′   reverse primer for *FAA*4 gene deletion
  Δ*DGAI*-*F*   5′ATACATAAGGAAACGCAGAGGCATACAGTTTGAACAGTCACATAACAGCTGAAGCTTCGTACGC3′      forward primer for *DGAI* gene deletion
  Δ*DGAI*-*R*   5′CCTTATTTATTCTAACATATTTTGTGTTTTCCAATGAATTCATTAGCATAGGCCACTAGTGGATCTG3′   reverse primer for *DGAI* gene deletion
  *acot*-*F*    5′GAAGAAGCGGCCGCATGCTAGCCAAAGGTAAGCC3′                                    forward primer for *acot* integrated in pMRI plasmid
  *acot*-*R*    5′CCTTAGATCTTCAAGGACTAGGTCTCTTGTCACC3′                                    reverse primer for *acot* integrated in pMRI plasmid

The *car* gene encoding CAR and *sfp* gene encoding SFP were artificially synthesized with SpeI/PacI and BamHI/XhoI endonuclease sites, respectively, and inserted into the pESC-leu plasmid directly.

###### Free Fatty Alcohol Compositions between the Engineered Strains Δ*FAA*1/Δ*FAA*4-*car*-*sfp* (Engineered Strain 1) and Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot*-*car*-*sfp* (Engineered Strain 2)

                               compositions                                           
  --------------------- ------ -------------- ----- ----- ------ ------ ------ ------ ------
  engineered strain 1   24.3   1.3            3.1   2.7   11.4   40.7   16.5   12.8   11.3
  engineered strain 2   31.2   1.1            2.3   2.1   11.3   45.3   15.4   12.0   10.5

From our study, it was obvious that the CAR exhibited activity toward FFAs with a broad range of chain length, from C8 to C18, and the efficient conversion of FFAs to the fatty acid derivatives also depended on the presence of SFP. The results herein were in accordance with the previous report, in which the CAR was characterized and shown to accept a broad range of aliphatic fatty acids.^[@ref18]^ The SFP was necessary for the maximum activity of CAR, and as a result, the coexpression of CAR and SFP in this study converted the accumulated FFAs into fatty acid derivatives successfully.

Until now, the CAR has been exploited from limited sources such as *Mycobacterium marinum*([@ref18],[@ref21]) and found to convert the FFAs to the corresponding aldehydes. However, in this study, no fatty aldehydes were detected in the engineered strain, but only fatty alcohols with different chain lengths were accumulated. It was reported that *S. cerevisiae* contained various endogenous aldehyde reductases (ALRs),^[@ref22]^ which could effectively convert the synthesized fatty aldehydes into the corresponding fatty alcohols. As such, the majority of FFAs were flux to the formation of fatty alcohols and the trace amounts of fatty aldehydes generated were not detectable.

Enhanced Production of Fatty Alcohols in Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot*-*car*-*sfp*-Engineered Strain {#sec2-4}
-----------------------------------------------------------------------------------------------------

Whereas the accumulated FFAs that resulted from the engineered pathway were secreted into the culture broth, the rest of the fatty acids were stored mainly in the form of TAGs and sterol esters in *S. cerevisiae*. According to our previous study, the acyl-CoA:DAGAT was the rate-limiting enzyme involved in the synthesis of TAGs from fatty acyl-CoAs and its deletion resulted in the release of fatty acyl-CoAs.^[@ref15]^ In this study, the *dga*I gene encoding the DAGAT was codeleted with *FAA*1 and *FAA*4, and the acyl-CoA thioesterase responsible for the conversion of fatty acyl-CoAs to FFAs was introduced in the modified yeast strain, to supply more FFAs for the production of fatty acid derivatives. For Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot*, because no "converting enzymes" of *car* and *sfp* were expressed, no fatty alcohols were detected. On the other hand, in the Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot*-*car*-*sfp* strain, similar to the Δ*FAA*1/Δ*FAA*4-*car*-*sfp*-engineered strain, only fatty alcohols were detected and the profiles of the fatty alcohols were in agreement with those in the Δ*FAA*1/Δ*FAA*4-*car*-*sfp* strain ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). The concentration of total fatty alcohols increased from 24.3 to 31.2 mg/L, and that of the most abundant *cis*-9-hexadecenol (C16:1 fatty alcohol) reached 14.1 mg/L, an increase of 42.7%. 1-Tetradecanol (C14:0 fatty alcohol), 1-hexadecanol (C16:0 fatty alcohol), 1-octadecanol (C18:0 fatty alcohol), and *cis*-9-octadecenol (C18:1 fatty alcohol) increased by 27.2, 19.8, 19.6, and 19.2%, respectively ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). For the medium-chain fatty alcohol including 1-octanol (C8:0 fatty alcohol), 1-decanol (C10:0 fatty alcohol), and 1-dodecanol (C12:0 fatty alcohol), no further increase in yield was observed. In our previous study, the deletion of DAGAT resulted in no increase in medium-chain fatty acyl-CoAs,^[@ref15]^ and as a result, no more medium-chain FFAs were further supplied for the synthesis of fatty alcohols in this study. The production level of fatty alcohol in the Δ*FAA*1/Δ*FAA*4/*DGAI*-*car*-*sfp* was also investigated. The deletion of *DGAI* was previously demonstrated to accumulate fatty acyl-CoAs effectively. However, without the expression of acyl-CoA thioesterase, the accumulated fatty acyl-CoAs could not be efficiently converted to FFAs and thus cannot be used as precursors for the CAR. As a result, no more fatty alcohols were detected compared with Δ*FAA*1/Δ*FAA*4-*car*-*sfp*-engineered strain.

###### Increase in Fatty Alcohols in the Engineered Strain Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot*-*car*-*sfp* (Strain 2) Compared with That in the Engineered Strain Δ*FAA*1/Δ*FAA*4-*car*-*sfp* (Strain 1)[a](#t3fn1){ref-type="table-fn"}

  increase level       total (%)   C8:0 (%)   C10:0 (%)   C12:0 (%)   C14:0 (%)   C16:1 (%)   C16:0 (%)   C18:1 (%)   C18:0 (%)
  -------------------- ----------- ---------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
  strain 2--strain 1   28.4        1.2        1.3         2.1         27.2        42.7        19.8        19.2        19.6

The increase in the production levels in the engineered strain Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot*-*car*-*sfp* compared with those in the Δ*FAA*1/Δ*FAA*4-*car*-*sfp* was reflected as "%".

The comparison of the fatty acid content between Δ*FAA*1/Δ*FAA*4/*DGAI*-*acot* deletion strain with empty pESC plasmid and that with coexpressed CAR and SFP (Δ*FAA*1/Δ*FAA*4/*DGAI*-*acot*-*car*-*sfp*) found that the FFA content decreased significantly in the Δ*FAA*1/Δ*FAA*4/*DGAI*-*acot*-*car*-*sfp*-engineered strain, which accounted for only 26.2% of that produced in the Δ*FAA*1/Δ*FAA*4/*DGAI*-*acot* strain; especially, the myristyl acid, cetyl acid, palmitoleyl acid, stearic acid, and oleic acid decreased to 33, 37, 31, 43, and 43%, respectively ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}), demonstrating the successful conversion of FFAs to fatty acid derivatives by the coexpressed CAR and SFP.

![Comparison of fatty acid contents between Δ*FAA*1/Δ*FAA*4/*DGAI*-*acot* strain and Δ*FAA*1/Δ*FAA*4/*DGAI*-*acot*-*car*-*sfp* strain. The standard deviation was calculated from the three independent experimental results.](ao-2017-00065v_0004){#fig4}

Comparison of Production of Fatty Alcohols between Engineered Strains Based on an Increased Supply of FFAs and Fatty Acyl-CoAs {#sec2-5}
------------------------------------------------------------------------------------------------------------------------------

In *S. cerevisiae*, both fatty acyl-CoAs and FFAs are precursors of fatty acid derivatives, which can be directly converted to the corresponding component either by enzymes using acyl-CoAs as precursors such as FAR or by those with FFAs as precursors such as CAR. Herein, the comparison of the production levels of fatty alcohols between engineered strains based on an increased supply of FFAs (in this study) and fatty acyl-CoAs (previous study) was performed. Both the strategies resulted in the production of fatty alcohols without forming fatty aldehydes, which was due to the substrate specificity of FAR, belonging to the alcohol-forming type^[@ref14]^ and the existence of endogenous ALRs in *S. cerevisiae*,^[@ref22]^ converting the fatty aldehydes to the corresponding fatty alcohols. The production level of fatty alcohols in the two engineered strains was comparative, but interestingly, in the engineered strain based on increased supply of fatty acyl-CoAs, the mainly accumulated fatty alcohols were saturated fatty alcohols, especially 1-hexadecanol (C16:0 fatty alcohol), accounting for approximately 80% of the total fatty alcohols. On the other hand, in the engineered strain with increased supply of FFAs, the most abundant fatty alcohol was unsaturated fatty alcohol, especially *cis*-9-hexadecenol (C16:1 fatty alcohol), representing approximately 45% of the total fatty alcohols. The *cis*-9-octadecenol (C18:1 fatty alcohol) accounted for approximately 13% in the fatty acyl-CoA-accumulated strain, but it was not detectable in the FFA-accumulated strain. In addition, the medium-chain fatty alcohols with the carbon chain length from C8 to C12 were not detected in the acyl-CoA-accumulated strain but detectable in the FFA-accumulated strain.

While investigating the fatty acid profile in the two engineered strains, it was found that the deletion of *FAA*1 and *FAA*4 resulted in the accumulation of medium-chain FFAs including C8:0, C10:0, and C12:0; unsaturated FFAs including C16:1 and C18:1; and saturated FFAs including C14:0, C16:0, and C18:0 ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Among them, the C16:1 and C16:0 FFAs were found to be the most abundant and the medium-chain FFAs accounted for only a small part of the total FFAs. As a result, the expression of CAR with a broad substrate specificity resulted in the production of fatty alcohols, the profile of which was in agreement with that of the accumulated FFAs. In our previous study, the *DGAI* deletion strain resulted in no release of medium-chain fatty acyl-CoAs from TAGs and the FAR was demonstrated to exhibit the highest catalytic efficiency for C16:0 fatty acyl-CoA. As such, the profiles of fatty alcohols produced between engineered strains based on an increased supply of FFAs and fatty acyl-CoAs with expressed CAR and FAR, respectively, reasonably differ from each other.

In the past few years, tremendous efforts have been focused on the study of microbial production of fatty acids and their derivatives. Similarly to our work, Runguphan and Keasling directly overexpressed the FAR from *Mus musculus* to produce fatty alcohols in *S. cerevisiae* and followed by the replacement of strong constitutive promoter P~TEF1~ to the original promoter of genes involved in fatty acid synthesis; the production level of fatty alcohol reached more than 90 mg/L.^[@ref23]^ Zhou et al. engineered the yeast strain step by step based on the increased supply of FFAs.^[@ref24]^ The initial production of fatty alcohol reached 23.2 mg/L, which was comparable with our results. However, after the deletion of genes involved in endogenous conversion of fatty alcohols to fatty aldehyde and fatty acids, blocking the fatty acid degradation pathway, and coexpression of FAR and CAR, the fatty alcohol yield significantly increased. With further fed-batch strategies, the production of fatty alcohol reached 1.5 g/L. The current results already demonstrated the feasibility of the production of fatty acid derivatives based on the two different strategies and by a further combination of other strategies such as promoter replacement, by-pathway blockage, multiple enzyme coexpression, and fermentation optimization, large-scale production of fatty acid derivatives become realizable.

Conclusions {#sec3}
===========

In this study, an alternative strategy to supply FFAs as precursors for the synthesis of fatty acid derivatives was constructed. The codeletion of *FAA*1 and *FAA*4 together with *DGAI*, followed by the integration of acyl-CoA thioesterase, successfully enhanced the supply of FFAs with the carbon chain length from C8 to C18. The coexpression of the CAR and SFP further converted the accumulated FFAs into their corresponding fatty acid derivatives. Because of the existence of endogenous ALRs in *S. cerevisiae*, the engineered strain mainly produced fatty alcohols but not fatty aldehydes. The results obtained herein not only demonstrated the efficiency of the constructed pathway for the production of fatty alcohol but also solved the bottleneck involved in the utilization of fatty acids as precursors for the synthesis of fatty acid derivatives directly.

Methods {#sec4}
=======

Strains and Cultivation {#sec4-1}
-----------------------

The *S. cerevisiae* BY4741 (ura3Δ, ΔMAT, his3Δ, leu2Δ, met15Δ) was used as a parental strain in this study and cultivated in yeast extract peptone dextrose (YPD) complete medium \[1% yeast extract, 2% peptone, and 2% [d]{.smallcaps}-glucose (w/v)\]. The engineered strains harboring *LEU*2-based plasmids (pESC-leu) were selected on agar plates of the yeast nitrogen base dextrose (YNBD) minimal medium without leucine \[6.7 g/L yeast nitrogen base, 5 g/L ammonium sulfate, 2% [d]{.smallcaps}-glucose (w/v), and 0.67 g/L leucine dropout amino acid mixture\]. The gene deletion strains with *His*5-based cassettes were selected on agar plates of YNBD minimal medium plates without histidine \[6.7 g/L yeast nitrogen base, 5 g/L ammonium sulfate, 2% [d]{.smallcaps}-glucose (w/v), and 0.65 g/L histidine dropout amino acid mixture\], and those with *Kan*MX cassette were selected on agar plates of YPD medium containing 200 mg/L Geneticin (G418). All cultivations were performed at 30 °C and 200 rpm (if necessary).

When cultivating the strains for the investigation of fatty acid and fatty acid derivatives, single colonies were selected from the corresponding agar plate. The wild-type strain and engineered gene deletion strains with empty pESC plasmid or recombinant pESC plasmids were cultivated overnight in 5 mL YNBD minimal medium without leucine. After that, the seed liquid was inoculated into a 50 mL YNB minimal medium without leucine, and 1% raffinose (w/v) together with 2% (w/v) galactose was added. The expression of target genes under GAL1/GAL10 promoters was induced by the initial addition of galactose in the absence of glucose at 30 °C and 200 rpm. The cell concentration was measured according to the value of OD~600~, and after the galactose induction for approximately 24 h and the cell growth reached a stationary phase, the cells were centrifuged and collected for further applications.

Construction of Engineered Strains {#sec4-2}
----------------------------------

The Δ*FAA*1/Δ*FAA*4 double gene disruption strain was constructed according to the homologous recombination strategies:^[@ref25]^ the polymerase chain reaction (PCR)-amplified fragment containing the loxP-*His*5-loxP gene disruption cassette and 45 nucleotide stretches that are homologous to the sequences upstream of the start codon of *FAA*1 gene and downstream of the stop codon were used for the homologous recombination of the *FAA*1 gene. The deletion of *FAA*4 gene was based on the *FAA*1 single gene disruption strain, and the generated PCR fragment containing the loxP-*Kan*MX-loxP and 45 nucleotide stretches that are homologous to the sequences upstream of the start codon of *FAA*4 gene and downstream of the stop codon was used for the homologous recombination of the *FAA*4 gene. Once the Δ*FAA*1/Δ*FAA*4 double gene disruption strain was obtained, the *Kan*^*r*^ marker was rescued according to the method described previously: The mutant strain was transformed with the plasmid pSH47, which carries the *cre* recombinase gene and *URA*3 marker gene. After growing in the YPD medium, the cells were shifted to the YPG (galactose) medium to remove the *Kan*^*r*^ marker gene. The colonies were detected on both YPD and replica-YPD plus G418 plate. The marker-rescued mutant strain was further used for the deletion of *dgaI* gene with the same strategy, and the *Kan*^*r*^ marker was rescued again.

The carboxylic acid reductase gene (*car*) from *M. marinum* (accession no. WP_012393886) and 4′-phosphopantetheinyl transferase gene (*sfp*) from *Bacillus subtilis* (accession no. Q9F4F7) were synthesized by GenScript and codon-optimized for *S. cerevisiae*. The two synthesized gene fragments were flanked with a pair of *Spe*I/*Pac*I and *BamH*I/*Xho*I restriction enzyme sites, which were digested by the corresponding endonucleases and inserted in the two multicloning sites of the predigested pESC-leu plasmid. The recombinant plasmid and empty pESC-leu were then transformed into the Δ*FAA*1/Δ*FAA*4 mutant strain separately to construct the engineered strains Δ*FAA*1/Δ*FAA*4-pESC and Δ*FAA*1/Δ*FAA*4-*car*-*sfp*. The acyl-CoA thioesterase gene (*acot*) fragment from *M. musculus* (accession NM_145444.3) lacking the C-terminal peroxisomal targeting peptide was obtained in our previous work and was inserted into the pMRI plasmid provided by Prof. Yu^[@ref26]^ between the *Not*I and *Bgl*II endonuclease sites. The pMRI recombinant plasmid containing *acot* was then digested by *sfi*I endonuclease and transformed into the Δ*FAA*1/Δ*FAA*4/Δ*DGAI* deletion strain. The functional module was integrated into the HO locus, generating the engineered strain Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot*. The above-constructed pESC-*car*-*sfp* plasmid was then transformed into the Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot* strain, resulting in Δ*FAA*1/Δ*FAA*4/Δ*DGAI*-*acot*-*car*-*sfp*. The primers used in this study are listed in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

Metabolites Extraction and Derivatization {#sec4-3}
-----------------------------------------

Cells (5 mL) growing in the corresponding culture medium at the stationary phase were centrifuged and collected. After washing twice with distilled water, the cells were resuspended in 400 μL of ethyl acetate, and 5 μL of heptadecanoic acid (10 mg/mL) was added as internal control. The cell samples were added with the same volume of glass beads of diameter 425--600 μm and vortexed in a bead mill with a vortex frequency of 4.0 m/s and a vortex time of 20 s for one cycle. Ten cycles for each sample was performed to break the cells, and the obtained cell lysis was centrifuged at room temperature at 10 000 rpm for 10 min. The supernatants containing the extracted metabolites were collected for derivatization.

For the derivatization of fatty acids, 40 μL of *N*,*O*-bistrifluoroacetamide (BSTFA) with 1% chlorotrimethylsilane (TMCS) was added to each of 60 μL samples and reacted at 70 °C for 30 min. The reaction samples were then shaken at room temperature for another 30 min and then transferred to vials for GC--MS detection. Various concentrations of fatty alcohol standards with carbon chain length from C8 to C18 were taken for the derivatization following the same protocol and analyzed using GC--MS under the same conditions. Quantitative calculation of fatty alcohols in the samples was carried out according to the standard curve. Three biological replicates were performed. For the derivatization of fatty acids, the extracted metabolites were evaporated to dryness. Boron trifluoride (BF~3~) solution (500 μL) with 14% methyl alcohol (MeOH) was added into each of tubes containing the dried samples and was reacted at 95 °C for 20 min. After that, 50 μL of saturated sodium chloride (NaCl) solution was added to terminate the reaction. *n*-Hexane solution (300 μL) was then added, and the sample tubes were shaken at room temperature for 1 h. The *n*-hexane layer containing the derived fatty acids (fatty acid methyl esters, FAMEs) was transferred to the vials for GC--MS detection. Standard curves of the FAME standard mix (with C8--C24 carbon chain length, Sigma) were used as references for the quantitative calculation of FFAs in the extracted samples. Three biological replicates were performed.

GC--MS Procedure and Data Analysis {#sec4-4}
----------------------------------

The GC--MS system (Agilent 5975C) equipped with a DB-5 capillary column with 30 m length, 0.25 μm thickness, and 250 μm inner diameter was used to analyze the samples. Samples measuring 1 μL were injected into the GC--MS equipment and separated by the DB-5 capillary column in a splitless mode. The GC--MS program was performed as follows: The temperature of the inlet and the MS source was set at 250 and 230 °C, respectively. The initial temperature of the oven was set at 80 °C, and then the gradient was increased to 250 °C with a ramp of 7 °C/min. The carrier gas was helium, and its flow rate was set at 1.0 mL/min. The chromatogram and identification of mass spectra were acquired using the Shimadzu GC--MS solution software. The final concentrations of the fatty acid derivatives and the fatty acids were calculated with fatty alcohol standards and FAME standards as references. All experiments were performed in three biological replicates.
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